We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
+5.3%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.53B
AUM Growth
+$159M
(+3%)
Cap. Flow
-$12.4M
Cap. Flow
% of AUM
-0.22%
Top 10 Holdings %
Top 10 Hldgs %
20.92%
Holding
797
New
64
Increased
251
Reduced
262
Closed
82
Avg Time Held
1.1
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
0.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ulta Beauty
ULTA
|
+$42M |
| 2 |
CF Industries
CF
|
+$41.4M |
| 3 |
BEAV
B/E Aerospace Inc
BEAV
|
+$36.2M |
| 4 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$33.3M |
| 5 |
Sunoco
SUN
|
+$29.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$55.7M |
| 2 |
ITC
ITC HOLDINGS CORP
ITC
|
+$38.9M |
| 3 |
AGN
Allergan Inc
AGN
|
+$38.3M |
| 4 |
Accenture
ACN
|
+$37.2M |
| 5 |
Tesla
TSLA
|
+$35.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.43% |
| 2 | Financials | 16.55% |
| 3 | Consumer Discretionary | 12.19% |
| 4 | Industrials | 12.01% |
| 5 | Technology | 10.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
226
Deere & Co
DE
$173B
| $1.5M | 0.03% |
17,116
+141
| +0.8% | +$12.5K |
2013 Q2
7 quarters
|
|
227
DELISTED
Ansys
ANSS
| $1.48M | 0.03% |
16,825
-4,410
| -21% | -$373K |
2014 Q1
4 quarters
|
|
228
Eli Lilly
LLY
$1.12T
| $1.48M | 0.03% |
20,399
+1,655
| +9% | +$118K |
2013 Q2
7 quarters
|
|
229
Blackrock
BLK
$176B
| $1.48M | 0.03% |
4,036
+8
| +0.2% | +$2.9K |
2013 Q2
7 quarters
|
|
230
VF Corp
VFC
$6.62B
| $1.47M | 0.03% |
20,671
+96
| +0.5% | +$6.65K |
2014 Q1
4 quarters
|
|
|
AEK.CL
231
DELISTED
Aegon NV
AEK.CL
| $1.47M | 0.03% |
51,566
-1,000
| -2% | -$28.4K |
2013 Q2
7 quarters
|
|
232
Yum! Brands
YUM
$41.1B
| $1.46M | 0.03% |
25,861
-1,912
| -7% | -$104K |
2013 Q2
7 quarters
|
|
233
US Bancorp
USB
$91.5B
| $1.44M | 0.03% |
33,067
+4,889
| +17% | +$214K |
2013 Q2
7 quarters
|
|
234
Vanguard Morningstar Small-Cap ETF
VB
$76.9B
| $1.44M | 0.03% |
11,784
+3,303
| +39% | +$391K |
2014 Q1
4 quarters
|
|
235
Stryker
SYK
$113B
| $1.44M | 0.03% |
15,636
+1,705
| +12% | +$159K |
2013 Q2
7 quarters
|
|
236
Canadian Pacific Kansas City
CP
$76.8B
| $1.44M | 0.03% |
39,400
-2,290
| -5% | -$84.5K |
2013 Q4
5 quarters
|
|
237
Norfolk Southern
NSC
$73.4B
| $1.4M | 0.03% |
13,635
-50
| -0.4% | -$5.35K |
2013 Q2
7 quarters
|
|
|
VNRBP
238
DELISTED
Vanguard Natural Resources LLC 7.625% Series B Cumulative Redeemable Perpetual Preferred Unit
VNRBP
| $1.35M | 0.02% |
62,770
+5,320
| +9% | +$114K |
2014 Q1
4 quarters
|
|
239
Fastenal
FAST
$58.5B
| $1.35M | 0.02% |
129,948
-464
| -0.4% | -$5.01K |
2013 Q2
7 quarters
|
|
240
DELISTED
INVESCO MORTGAGE CAPITAL INC. 7.75% Fixed-To-Floating Series B Cumulative Redeemable Preferred Stock
IVR.PRB
| $1.34M | 0.02% |
54,700
+8,400
| +18% | +$204K |
2014 Q3
2 quarters
|
|
241
ICICI Bank
IBN
$108B
| $1.33M | 0.02% |
141,159
+3,576
| +3% | +$37.1K |
2014 Q1
4 quarters
|
|
242
Merck
MRK
$360B
| $1.32M | 0.02% |
24,157
-617
| -2% | -$34.9K |
2013 Q2
7 quarters
|
|
243
Las Vegas Sands
LVS
$24.6B
| $1.31M | 0.02% |
23,791
-19
| -0.1% | -$1.06K |
2013 Q2
7 quarters
|
|
244
DELISTED
PALL CORP
PLL
| $1.31M | 0.02% |
13,005
-414
| -3% | -$41.8K |
2013 Q2
7 quarters
|
|
245
Brookdale Senior Living
BKD
$2.41B
| $1.3M | 0.02% |
34,365
-2,495
| -7% | -$91.4K |
2014 Q3
2 quarters
|
|
246
LKQ Corp
LKQ
$5.62B
| $1.28M | 0.02% |
50,110
-845
| -2% | -$21.9K |
2013 Q2
7 quarters
|
|
247
Palo Alto Networks
PANW
$280B
| $1.26M | 0.02% |
51,690
-21,930
| -30% | -$491K |
2014 Q1
4 quarters
|
|
248
Lazard
LAZ
$3.52B
| $1.25M | 0.02% |
23,700
-4,993
| -17% | -$246K |
2013 Q2
7 quarters
|
|
249
Colgate-Palmolive
CL
$75B
| $1.24M | 0.02% |
17,830
-2,045
| -10% | -$141K |
2013 Q2
7 quarters
|
|
250
Jefferies Financial Group
JEF
$10.3B
| $1.23M | 0.02% |
61,560
+4,315
| +8% | +$89.2K |
2013 Q2
7 quarters
|
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q1 2015 Portfolio in Review
As of Q1 2015, Geneva Advisors held 797 positions worth $5.53B, up 3% from $5.37B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Geneva Advisors's Q1 2015 filing shows 64 new, 251 increased, 262 reduced and 82 closed positions. Its largest new stake was Ulta Beauty: 303,437 shares worth $45.8M. The largest sale was Johnson & Johnson, an estimated $55.7M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
- Geneva Advisors's largest Q1 2015 buy was Ulta Beauty: 303,437 shares worth $45.8M.
- Geneva Advisors added most to CF Industries in Q1 2015, an estimated $41.4M increase.
- Geneva Advisors's biggest Q1 2015 reduction was Johnson & Johnson, cutting an estimated $55.7M.
- Geneva Advisors fully exited Allergan Inc in Q1 2015, selling an estimated $38.3M.
- Geneva Advisors's ten largest holdings make up 21% of its $5.53B portfolio in Q1 2015.
- Geneva Advisors opened 64 new positions and closed 82 in Q1 2015.
- Geneva Advisors's portfolio value rose 3% quarter-over-quarter to $5.53B.
Based on Geneva Advisors's 13F filing for Q1 2015, filed 5 May 2015.